Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R.
Olincy A, et al. Among authors: harris jg.
Arch Gen Psychiatry. 2006 Jun;63(6):630-8. doi: 10.1001/archpsyc.63.6.630.
Arch Gen Psychiatry. 2006.
PMID: 16754836
Clinical Trial.